BBHC
PBE icon

Brown Brothers Harriman & Co’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-500
Closed -$27K – 1264
2019
Q2 		$27K Hold
500
– – ﹤0.01% 695
2019
Q1 		$28K Buy
+500
New +$26.4K ﹤0.01% 675

Other funds holding PBE

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PA
PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Brown Brothers Harriman & Co's PBE Position: Q3 2019 in Review

Brown Brothers Harriman & Co sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2019, closing a stake of 500 shares — an estimated $27K sold.

Brown Brothers Harriman & Co first reported a position in PBE in Q1 2019 and held it in 2 quarters. The position peaked at $28K in Q1 2019. 73 funds tracked by Wall St. Rank hold PBE as of Q3 2019.

  • Brown Brothers Harriman & Co reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2019 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 500 Invesco Biotechnology & Genome ETF shares in Q3 2019, an estimated $27K.
  • Brown Brothers Harriman & Co first reported a position in Invesco Biotechnology & Genome ETF in Q1 2019 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Invesco Biotechnology & Genome ETF position peaked at $28K in Q1 2019.
  • 73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2019, filed 14 Nov 2019.